NCT01460108

AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation

Utility of the AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation Assessed by the Chartis System

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology · Network
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to characterize the safety and efficacy of the AeriSeal System in patients with advanced upper lobe predominant emphysema and significant collateral ventilation as determined by the Chartis System.

Detailed description

This is an investigator initiated, open-label, uncontrolled study to prospectively characterize the safety and efficacy of the AeriSeal System in patients with advanced upper lobe predominant emphysema found to have significant collateral ventilation using the Chartis System.

Conditions

• Pulmonary Emphysema
• COPD
• Lung Diseases

Interventions

Type	Name	Description
DEVICE	AeriSeal System	20 mL

Timeline

• Start date: 2011-04-01
• Primary completion: 2012-12-01
• Completion: 2013-06-01
• First posted: 2011-10-26
• Last updated: 2011-10-27

Locations

1 site across 1 country: Austria